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17.1
Human papillomaviruses in neck metastases of squamous cell carcinoma
of the head and neck
M. Hoffinann', T. Kahn2, C.G. Mahnke', B.M. Lippert', T. Gorogh', J.A. Werner',
'Dept. ofORL, University ofKiel, 2German Cancer Center, Heidelberg, Germany
Applying the most accurate HPV detection methods presently available a HPV
prevalence of about 26% can be expected in squamous cell carcinomas of the
head and neck, as we have shown earlier. In this study, we investigated the
presence ofdetectable HPV DNA in neck metastases (NM) of this tumor entity
by the same methods. Furthermore, in eight cases the correlation of primary
tumor (PT) and NM ofthe same patients could be analyzed.
,,Hot start" polymerase chain reaction employing type specific primers as well
as consensus primer pairs followed by Southern blot hybridization of the PCR
products was performed on DNA extracted from fresh frozen material of 27
NM and 9 PT samples.
HPV DNA was detectable in 13/27 (48%) NM specimens and in 4/9 (44.3%)
PT specimens. HPV 16 could be identified in 5/13 (38.8%) HPV positive NM
specimens and in 3/4 (75%) positive PT specimens; in nine cases the infecting
HPV type could not yet be identified. In 3/4 (75%) HPV positive PT cases the
investigated NM samples showed detectable HPV DNA as well, and in 4/5
(80%) cases both NM and PT samples of the same patients were HPV
negative.
The prevalence of HPV DNA in PT of patients that develop resectable NM
seems to be higher than in those that do not, though the high prevalence rate
might also be due to the small number of cases investigated. NM show
detectable HPV DNA in 48% of the cases reflecting an association of HPV
infection and progression to metastases. The presence of HPV 16 DNA in
38.8% ofthe positive NM cases points to a special role ofthis ,,high risk" HPV
type also in developing NM. The high rate of HPV positives that could not be
identified might be due to integration of the viral DNA into the genome
thought to be afurther sign oftumor progression. The strong correlation of the
HPV status in PT and NM of the same patients (77.8%) supports the
hypothesis that HPV specifically infects the tumor cell.
17.3
The degree of cell surface sialylation of metastases of head and
neck cancer
F Riedel, W. Bergler, A. Baker-Schreyer, K. G6tte, G. Petroianu, K.
Hormann, Dept. ofORL, Mannheim, University ofHeidelberg, Germany
Purpose: The sialoglycans and the degree ofsialylation on the cell
surface are of increasing interest because of the possible
contribution to metastasis and invasion. Primary tumors and
metastasis may differ in the degree ofsialylation.
Material and methods: Cell surface sialylation of 30 lymph node
metastases and 30 squamous cell carcinomas ofthe head and neck
was determined by a new histobiochemical assay on cryostat
sections which is based on the enzymatic introduction of a
fluorescence-labelled sialic acid (CMP-9-fluoresceinyl-NeuAc) into
lactosaminyl type (Gal 3 1-4 GlcNAc) oligosaccharide chains of
cell surface glycoproteins by a-2,6-sialyltransferase. To compare
degree of sialylation with the total amount of sialylation sites a
pretreatment with sialidase for desialylation was required.
Results: We observed a significant (p=O.001) higher amount of
lactosaminyl type binding sites for sialic acid on metastases
compared to the primary tumors. Pretreatment with sialidase could
detect a significant amount of sialylation on primaries and
metastases, showing a lower degree ofsialylation in metastases. In
primary tumors no correlation was seen between the amount of
binding sites and tumor localization, TNM-stage or histological
grading ofthe tumors.
Conclusions: A higher degree of sialic acid free lactosaminyl
glycans on the cell surface ofhead and neck tumors seems to be
correlated with the occurence of metastasis. Our new
histobiochemical method turned out to be effective, reliable and
little laborious.
17.2
p53 immunoreactivity independent of TNM status and HLA-class I in
larynx cancer patients?
S. Gottschlich, E. Westphal', I. Rathcke, B.M. Lippert, T. Gorogh, T. Wilms,
J.A. Werner, Dept. of ORL, 'Dept. of Immunology, University of Kiel,
Germany
p53 antibodies are a fairly new serological parameter in cancer
patients to determine the p53 status of these patients. The actual
mechanism and cause why p53 reaches immunogenicity is
unknown, but several studies suggest a prognostic value for p53
antibodies in cancer patients. Ninety-five larynx cancer patients
were investigated for their p53 antibody status with ELISA and
their HLA class I was determined. The cancer patients were staged
according to the TNM-system (NO n=47, N1 n=19, N2 n=29; Ml
n=2) of the UICC. Eighteen of the patients (18.9%) were
seropositive for p53 antibodies. No correlation between the NM
status and HILA class I ofthe larynx cancer patients and their p53
antibody status was observed. These preliminary results seem to
indicate that the p53 immunoreactivity is independent ofthe HLA
class I in larynx cancer patients and that p53 antibodies do not
indicate a higher probability of a primary larynx carcinoma to
metastasize.
17.4
Expression of metalloproteinases and their inhibitors in squamous cell
carcinoma cell lines of the head and neck
H.G. Schulz, T. Gorogh, J. Baumken, S. Hoft, J. St6hlmacher, B.M. Order,
J.A. Werner, Dept. of. ORL, University ofKiel, Germany
Background: Matrix metalloproteinases (MMP) are a family of
proteolytic zinc metalloenzymes implicated in the invasion and
metastasis of many cancers. The ability of carcinoma cells to
produce extracellular matrix degrading enzymes plays an important
role in the malignant behaviour ofthe neoplasms. Methods: Total
RNA from 10 laryngeal squamous cell carcinoma (SCC) cell lines with
different metastatic potential and 5 keratinocyte celllines was reverse
transcribed and 1ien amplified by polymerase chain reaction (RT-
PCR). Specific oligonucleotid primers for M P-1, MMP-2 and
TIMP-1, TIMP-2 were used for amplification. Results:The results
showed the presence of MMP-1 positive in 100% of the SCC's
and 80% of the keratinocytes. MMP-2 was positive in 100% of
the tumor cell lines and 80% of the keratinocytes. The inhibitor
TIMP-1 was detected in 40% of the SCC's and 60% of the
keratinocytes whereas inhibitor TIMP-2 was found positive in 50%
ofthe tumors and 80% of the keratinocytes. The results showed
gene expression ofMMP's more often in tumor cell lines whereas
gene expression of their inhibitors TIMP's was detected more
frequently in benign keratinoyte cell lines. Conclusions: Our
findings suggest that the MMP-TMIMP profile may be a tool for
prognostic evaluation of the malignant potential of a tumor.
Although there are differences in gene expression ofMMP's and
TIMP's in tumor cell lines and keratinocytes, fiurther investigations
with regards to tumor invasiveness and lymph node metastases will
be necessary for understanding the role ofMMP's and TIMP's in
the emergence ofcancer.Tumormarkers, Virus, Neck dissection, Miscellaneous 51
17.5
MMP and TIMP mRNA expression in head and neck squamous cell
carcinomas: a tentative correlation with metastatic potential?
J. Baumken, B.M. Lippert, H.G. Schulz, B.J. Folz, M. Seiwerts, E.
Weber, J.A. Wemer, Dept. ofORL, University ofKiel, Germany
Background: Matrix metalloproteinases (MMP) are proteolytic
enzymes capable ofdegrading tissue components. Meanwhile there
is some evidence that divergence in the secretion of MMP4s or
alterations in the differential control by their tissue inhibitors of
metalloproteinases (TIMP) play a crucial role in the emergence of
metastases. Methods: Gene expression of MNMP-1, MMP-2, and
TIMP-1, TIMP-2 was quantitative analyzed by reverse
transcription-PCR in 48 specimen ofhead and neck squamous cell
carcinomas (HNSCC) with different metastatic potential. Results:
Expression ofMMP-1 could be detected in 20,8% of the tumors
with and in 45,8% without lymphnode metastases. Within all
tumors with positive lymphnodes MMiP-2 was expressed in 95,8%
whereas MMP-2 was expressed in 45,8% with negative
lymphnodes. TIMP-1 was found positive in 45,8% ofthe tumors
with positive and in 83,3% of the tumors with negative
lymphnodes. TIMP-2 was positive in 4,2% ofthe tumors with and
in 50% ofthe tumors without lymphnode metastases. We found a
correlation between the expression of MMP-2 and inhibitor
TIMP-2 and a weak correlation between the expression ofMMP-1
and inhibitor TIMP-1 and the occurrence of lymphnode
metastases. Conclusions: To our knowledge this is the first study,
that shows a correlation between MMP- and TIMP-expression and
the metastatic potential of HNSCC using this method. Final
statements will only be possible with the investigation ofa greater
number ofpatients and consideration offurther clinical parameters,
e.g. grading and tumor location.
17.7
Is telomerase activity a possible marker for the metastasis of head and neck
cancer?
S. Koscielny, W. Fiedler*, R. Dahse*, J. Sonntag*, S.M.E. Hofinann*, U. Claussen*,
E. Beleites, G. Emst*, Dept. of ORL, *Inst. of Human Genetic and Anthropology,
University ofJena, Germany
Telomerase, the enzyme which is able to stabilize the telomeres of
the chromosomes, is closely associated with the immortalization of
cells.
In order to evaluate whether the determination of telomerase
activity is a possible prognostic marker for the metastatic potential
of head and neck cancers we investigated 37 squamous cell
carcinomas (SCC) ofthe oropharynx, 12 SSC ofthe hypopharynx,
25 SSC ofthe larynx and 4 SCC of the oral cavity. In 29 cases
with oropharyngeal/ 15 with laryngeal/ 5 with hypopharyngeal/ 2
with oral cavity SCC the telomerase status in the corresponding
lymph nodes were tested, too.
Approximately 75% of the primary tumors were found to be
telomerase positive. In all histological positive nodes we detected
telomerase activity. Interestingly, telomerase activity was also
present in 90% ofthe histological negative lymph nodes. The latter
may be due to activated lymphocytes which are known to be
telomerase active.
By correlating clinical and molecularbiological datas we will
discuss our conclusion that the detection oftelomerase activity in
primary head and neck tumors isnot necessarily a reliable predictor
forthe metastastic potential ofthese tumors.
17.6
New definition of the tumor margin by the expression of EP-
CAM
M. Andratschke, S. Chaubal, S. Lang, R. Zeidler, B. Wollenberg, Dept.
ofOtorhinolaryngology, LM University ofMunich, Germnany
The epithelial glycoprotein 40 (EGP40), also known as Ep-CAM,
is a transmembrane glycoprotein that is expressed on the
baso-lateral surface ofmanyhuman epithelia. The exact function of
the molecule is still unknown, but the molecule is involved in
Ca++-independent intercellular adhesion. The protein is expressed
by 98% ofthe squamous head and neck carcinomas and is absent
in normal squamous epithelia. The aim of our study was the
expression ofEp-CAM in the marginal zone ofthe tumor. Probes
ofprimary HNSCC, epithelium 5mm close to the tumormargin and
healthy epithelium were taken intraoperatively and snapfrozen in
liquid nitrogen. An RT-PCR was performed with primers for
Ep-CAM. The main tumor showed high expression of Ep-CAM.
This expression gradually diminishes by enlarging the distance to
the tumor margin and becomes negative in healthy mucosa. Future
immumhistochemical staining results will correlate this finding with
the degree ofdysplasia along the tumor margin and its surrounding
tissue. Equivalent to the findings ofp53-mutations along the tumor
border in HNSCC, Ep-CAM expression could be a new marker for
redefining the real tumor margin, urging the need to also resect
dysplastic tissue.
17.8
Proliferative activity, determined by the monoclonal antibody KiSll, in
correlation to survival in patients with lymph node metastasis of
hypopharyngeal squamous cell carcinoma
C. Kuropkat, R.W. Huang, M. Hoffinann, R. Parwaresch, B.M. Lippert,
J.A.Werner, Rush Univ. Chicago, USA, Univ. ofKiel, Germany
Introduction: Recently, we found a significant correlation
between the immunohistochemically determined proliferation
status and the survival ofpatients with squamous cell carcinoma of
the hypopharynx (SCCH). The aim ofthis study was to verify the
same relationship for the lymph node metastasis (LNM) of these
tumors. Additionally we compared the proliferation indices of
primary tumor ,and LNM. Material and methods: In a
retrospective study we immunohistochemically investigated the
proliferative activity of paraffin-embedded LNM of 49 patients
with primary SCCH. We used the monoclonal antibody Ki-SI 1,
which recognizes the Ki-67-antigen. The 5-year-survival was
calculated according to the Kaplan-Meier-technique. Results:
Patients with low (.45%) proliferating LNM had a significantly
higher 5-year-survival-rate (44%) than those with high (>45%)
proliferation LNM, who had a 5-year-survival-rate of 29%
(p<0.05). The LNM had a median proliferation rate of 52% in
correlation to 49% for the primary SCCH (p<0.223). Conclusion:
There is no significant difference in the proliferation rate of
primary SCCH and their LNM. Patients with high proliferating
LNM have a less favorable clinical outcome compared to those
with low proliferating LNM. The antibody Ki-Sl 1 seems to be a
potential tool to determine the proliferative activity and to predict
patient survival in primary SCCH aswell as in their LNM.52 Tumor markers, Virus, Neck dissection, Miscellaneous
17.9
Proliferative activity in early stages of metastases
M. Lorz, Bremervorde, Germany
A possible technique to study metastasis is to inject tumor cells
intravenously into healthy animals and to follow them up until
metastases arises. Proliferation in metastases can be determined by
combining the methods of autoradiography (Lorz, M. et al. 13th
meeting ESGCP, October 1984) and immunocytochemistry
(monoclonal antibodies).
Tritiated-thymidine (3H-TdR) tumor cells were injected into the
tail vein ofadult, syngenic Sprague-Dawley cure rats and resulted
in the development of lung metastases. Arrest of disseminated
tumor cells in a target organ does Pot necessarily result in
formation of metastases. Therefore a second label with 14C-TdR
was administered at different intervals after implanta.Jon of pre-
labelled tumor cells. The combination with antiproliferative
monoclonal antibodies reveals the possibility for further
investigations.
Despite the high rate of proliferation of most disseminated cells
shortly after arrest in the target organ, only few clones developed
into progressive metastastic foci indicating an inherent proliferative
and metastatic heterogenity.
17.11
Cyfra 21-1: an indicator for distant metastases in head and neck cancer?
J.D. Maass, A.M. Niemann, S. Gottschlich, B.M. Lippert, A. Oelerking, J.A.
Werner, Dept. ofOtorhinolaryngology, Head and Neck Surgery, University of
Kiel, Germany
Introduction: Patients with head and neck squamous cell
carcinoma (HNSCC) are usually followed-up clinically. During the
follow-up it is difficult to detect distant metastases at early stages,
while a locoregional tumor progression sometimes can be seen
quite easily. Cyfra 21-1, a novel tumor marker, was shown to
correlate with tumor size in HNSCC. Therefore, it seemed
worthwhile elucidating a possible role of cyfra 21-1 in the
metastastic progression ofHNSCC. Methods: During the follow-
up, we compared the course of cyfra 21-1 values in sera of
HNSCC patients with distant metastases (n=18) and without
distant metastases (n=310). Results: 17 of 18 patients with distant
metastases had cyfra 21-1 values above the threshold of2.2 ng/ml.
Initially high or suddenly rising cyfra 21-1 values during the
follow-up mostly preceded or coincided with the detection of
distant metastases. Conclusions: The presented results indicate
that cyfra 21-1 may be useful in the early diagnosis of distant
metastases in HNSCC. T'his may influence therapeutical decisions
that sometimes go along with disfiguring surgical procedures, e.g.
laryngectomy. The early detection ofdistant metastases may avoid
unnecessary suffering for these patients, who may then profit from
an early cooperation between different clinical departments and
alternative therapy plans.
17.10
Follow-up of patients with carcinoma of head and neck using the
tumor marker Cyfra 21-1 for early detection ofrecurrent disease
I. Doweck, M. Barak, N. Uri, E. Greenberg, Dept. ofORL, Biochemistry
Research Unit, Carmel Medical Center, Haifa, Israel
Cyfra 21-1 was reported as a new potential tumor marker for
squamous cell carcinoma ofhead and neck. In the present studywe
evaluated the additional value of Cyfra 21-1 in the follow up of
patients with head and neck cancer. The study included 38 patients
with primary detection of head and neck carcinoma, who were
followed up for at least one year during the different treatment
regimens. Patients were followed every month for the first year
after diagnosis and every three months for the following years.
Cyfra 21-1 was determined periodically using an Elisa kit. Clinical
suspicion ofrecurrence or a significant increase in the Cyfra 21-1
level (>25%) was further investigated byhistologicaltbiopsy.
Thirty eight patients were followed using Cyfra 21-1. Out of 38
patients, 12 had recurrent disease. In 10 ofthese patients (83%),
Cyfra 21-1 was elevated before or concomitantly with the clinical
detection ofthe recurrence. 26 patients had no clinical evidence of
disease during the evaluation. In 20 ofthem (77%), there was no
significant elevation in the marker levels during follow up.
Elevated levels ofthe marker without clinical evidence of disease
can be attributed to the mean lead time ofthe marker as compared
to clinical appearance ofthe disease.
Conclusion: Cyfra 21-1 was found as an additional useful tool for
the follow up ofpatients with carcinoma ofhead and neck.
17.12
Diagnosis and management of distant metastasis ofthe carcinoma of
the oropharynx andlarynx - experience from 1980 - 1990
S. Koscielny, J. Stein, B. Kratsch, Dept. of Otorhinolaryngology,
Unive;sity ofJena, Germany
Among other things the long time survival ofpatients with a head
and neck cancer is determined by the occurrence of distant
metastasis. Because ofthis fact we were interested in the rate of
distant metastasis by patients with a squamous cell carcinoma of
the oropharynx and larynx over 15 years from 1975 to 1990. All
patients were observed in our outpatient department at least 5
years after diagnosis oftheirtumor disease.
Patients: 163 p,atients with a carcinoma of the oropharynx and
170 patients with a carcinoma ofthe larynx were examined. The
number ofdistant metastasis and their management were analysed.
Results: In 11 (6,7%) ofthe patients with a laryngeal cancer (7
supraglottic and 4 glottic) we observed distant metastasis. It's
interesting that 8 ofthese patients had an NO-neck during the time
oftumor therapy. Among the patients with oropharyngeal cancer
18 (10,6%) developed distant metastases in course.
Most ofall distant metastases were located in the lungs. Over all
we observed three abdominal metastases and one metastasis ofthe
spine.Tumormarkers, Virus, Neck dissection, Miscellaneous 53
17.13
Cvytjcally deeenerated neck node metastases mimicking
malignoma in lateral cervical cysts
B.J. Folz, A.M. Niemann, B.M. Lippert, dd.A. Werner, Dept. of
Otorhinolaryngology, Head and Neck Surgery, University of Kiel, Germany
There is a lot of controversy about the existence of malignant
dedifferentiation of lateral cervical cysts. More likely than a primary malignoma in a branchial cyst is the occurrence of a cystically degenerated metastasis to the neck. The differentiation between these two
entities is of clinical importance for the patient in terms of diagnostic
measures and therapy. Between 1990 and 1996 pathology reports
revealed a squamous cell carcinoma in 5 patients who were clinically primarily diagnosed lateral cervical cyst. One female patient was
diagnosed malignant melanoma in a branchiogenic cyst. On ultrasound examination the preoperative findings had not been different from "normal" cervical cysts. To rule out metastatic disease all 6 patients
underwent a staging consisting of panendoscopy with tonsillectomy and
lasersurgical resection ofthe lingual tonsil.Histologic examination ofthe
specimen revealed a primary cancer in 3 patients (lingual tonsil: 2 cases,
palatine tonsils: I case). Clinically the areas had not been suspicious for
malignancy. One further patient developed a carcinoma in his base of
tongue within a year after initial diagnosis. These findings indicate that
metastatic disease should rather be considered than a primary malignancy
of a lateral cervical cyst. Still malignant dedifferentiation in lateral
cervical cysts does occur and histologic diagnosis of carcinoma in situ or
severe dysplasias confirm the lateral cervical cyst as the primary lesion.
However it should be recommended that these patients are referred to a
complete staging including multiple biopsies to exclude a metastasing
primary malignancy elsewhere in the upper aerodigestive passage,
especially as there appears to be a predisposition for carcinomas
originating from Waldeyers Ring to form cystic metastases to the neck.
17.15
Value of elective neck dissection as a staging procedure in
patients with head andneck cancer
S. Hoft, S. Eggers, B.M. Lippert, M. Weller, J.A. Werner, Dept. of
Otorhinolaryngology, Head and Neck Surgery, University ofKiel, Germany
Introduction: Lymph node metastases are often difficult to detect.
However, if present - detected or undetected - they severely
reduce the patient's chances of healing. A controversy evolves
around the useflIness of elective neck dissection. The aim of the
present study was to determine how often the posttherapeutic N-
status had to be changed due to a histopathological diagnosis
differing from No. In this respect the validity of the imaging
procedures in staging was investigated.
Patients and methods: From April 1996 until May 1997 12
patients with squamous cell carcinomas of the head and neck
underwent an elective neck dissection. The tumors were located in
the oral cavity (3), oropharynx (2), hypopharynx (1), and larynx
(6). All patients were staged with ultra sound. Additionally 7
patients had a CT, 4 an MRI, and1 patient had a CT and an MRI
ofthe neck.
Results: The histopathological diagnosis was NO in 9 cases, Nl in
2, and N2b in1 patient.
Conclusions: In one quarter ofthe patients lymph node metastases
were present that had not been detected in preoperative staging.
The study supports the point of view of different centers that an
elective neck dissection is either a staging method or in a
considerable number ofpatients a therapy.
17.14
Cystic carcinoma in cervical lymph nodes express a different
cytokeratin profile than benign lateral neck cysts
S. Regauer, A. Beham, Dept. ofPathology, University ofGraz, Austnra
"Branchiogenic carcinomas" (=cystic carcinomas located within
cervical lymph nodes) are metastases from squamous cell
carcinomas (SCC) of head and neck, especially ofWaldeyer-ring
origin. We compared the cytokeratin (CK) profile of 15 cystic
cervical lymph node metastases and their primary carcinomas (10
tonsils, 5 base of tongue) with that of benign lateral neck cysts
(LNC).
All lymph nodes contained poorly differentiated cystic malignant
sqamous epithelium (0.5
- 5m diameter) without transitions from
non-tumorous to dysplastic or frankly malignant epithelium with
uniform expression of"simple" CK 8 and 19 throughout the cystic
carcinoma but only very focal "simple" CK7 and "stratified-
epithelial-type" CK13 expression. The CK-profile of the primary SCC was identical to that ofthe cystic carcinoma in lymph nodes.
Expression of CK 4, 5, 10, 14, 17 and 18, typically present in
LNC, was not observed in either primary or metastatic carcinoma.
The CK-pattems of metastatic cystic SCC and primary SCC of
Waldeyer's ring origin are identical but distinctly different from the
CK-profile of benign LNC, which is characterized by an orderly
and differential expression of "simple" CK in basal cells and
"stratified-epithelial-type" CK in suprabasal cells (APMIS, 105,
623-630, 1997).
17.16
Neck lymph node biopsy did not increase the distantmetastases in AJCC T,
3Ni4 nasopharyngeal carcinoma patients
P.C. Pai, N.M. Tsang', C.F. Lin2, C.K. Tseng', S. Tang', 'Dept. of Rad. Oncology, 2Dept. of Public Health, Chang Gung College of Medicine and Technology, Linkou,
Taiwan
Purpose: To investigate whether the neck lymph node biopsy
procedure increases the distant metastases rate in AJCC TI-3NI-3
nasopharyngeal carcinoma (NPC) patients. Material and
Methods: From February 1979 to December 1991, 1181 NPC
patients were treated in Chang Gung Memorial Hospital radiation
oncology department. These patients completed the proposed
course of nasopharyngeal treatment equal or greater than 64 Gy
and were followed up for more than 5 years. Five hundred and
forty-three patiehts belonged to AJCC TI-3NI-3 stage and in which
88 cases had neck lymph node operation procedure (aspiration 7,
incision 39, excision 40, and dissection 2). Results: No statistical
difference is recognized in age, operation method, or the time
interval between operation and start oflocal treatment but sex, N
stage, and neck area electron boost. Discussion: In this study,
though it is suggested that neck lymph node operation before
local-regional irradiation do not increases the distant metastatic
rate in AJCC T1-3NI-3 NPC patients.54 Tumor markers, Virus, Neck dissection, Miscellaneous
17.17
Neck lymph node metastases affecting the distant metastases in
AJCC T4 nasopharyngeal carcinoma patients
C.-K.Tseng', N.-M. Tsang', S.-K. Lo2, 'Dept. of Radiation Oncology, 2Dept. of
Public Health, Chang Gung College ofMedicine and Technology, Linkou, Taiwan
Purpose: To study the risk factors affecting the distant metastases
in AJCC T4 nasopharyngeal carcinoma (NPC) patients. Material
and Methods: From February 1979 to December 1991, 1181
NPC patients were treated in Chang Gung Memorial Hospital
radiation oncology department. These patients completed the
proposed course ofnasopharyngeal treatment equal or greater than
64 Gy and were followed up for more than 5 years. Four hundred
patients were T4 cases (skull base destruction, brain invasion,
retrobulbar invasion, cranial nerve palsies or sphenoid sinus
invasion). Results: N stage is the only factor affecting the distant
metastases in AJCC T4 NPC patients (p=0.0001) after local
complete irradiation. Age, sex, pathology, sites of tumor
involvement, cranial nerve palsies, treatment interval, electron neck
boost dose or nasopharynx brachytherapy did not affect the
outcome ofAJCC T4 NPC patients. Conclusion: In this study, the
higher the N staging, the higher the probability of distant
metastases are recognized in AJCC T4 NPC patients. It suggests
that the NPC treatment outcome ofT4No NPC patients is different
from T4N3 though allbelong to stage 4 in AJCC staging.
17.19
Lymphoscintigraphy ofthe neckshowing aberrant lymphatic drainage
S. Hoft', K.H. Bohuslavizki2, S. Klutmann, E. Henze2, J.A. Werner, 'Dept.
of Otorhinolaryngology, Head and Neck Surgery, 2Dept. of Nuclear
Medicine, University ofKiel, Germany
Introduction: Lymphoscintigraphy is a standard procedure for detecting
sentinel lymph nodes in patients with malignant melanoma. We evaluated
patients with squamous cell carcinomas ofthehead and neck.
Patients and Methods: From August 1996 until June 1997 46 patients
with 47 squamous cell carcinomas ofthe head and neck were injected 50-
100 MBq Tc-99-m-colloid peritumorally. 20 minutes later 50 MBq Tc-
99-m-pertechnetate were injected intravenously to picture the body
contours. The nodal status of the tumors was NO=20, N1=7, N2a=2,
N2b=5, N2c=12, N3=1. 42 patients were scanned at 30 min and 4-6
hours after injection. 4 patients were scanned 24 hours after they had
been injected within the staging panendoscopy due to the localisation of
thetumor.
Results: In 11 cases no drainage was observed. 23 patients had an
ipsilateral and 12 patients with an unilateral tumor had an bilateral (n=9),
contralateral (n=1) or retropharyngeal (n=2) drainage. Ofthese patients 2
had lymph node metastases bilaterally. Thus, in 10 tumors (21%) with
ipsilateral metastases an unexpected lymphatic drainage concerning the
retropharyngeal and contralateral lymph nodes was observed. One patient
with a midline crossingtumor had a drainage onthe less affected side.
Conclusion: Cervical lymphatic drainage could not be predicted. Further
investigation has to be directed into evaluating sentinel lymph nodes and
their value ofpredicting metastatic disease in theneck.
17.18
Metastatic spread of adenoid cystic carcinoma of the salivary glands - A
retrospective analysis of50 cases
C.G. Mahnke, C. Kulkens, J. Preugschat, C. Wenzel, S. Saffran, J.A. Werner, Dept.
ofOtorhinolaryngology, Head and Neck Surgery, University ofKiel, Germany
Among salivary gland malignancies adenoid cystic carcinoma
(ACC) differs in that it often leadsto distant metastasis. The aim of
this study was to analyse the clinical course ofpatients diagnosed
with ACC with special consideration to metastasis.
The charts of all patients (n=50, m:26, f: 24) treated at the Dept.
of Otorhinolaryngology, Head and Neck Surgery, University of
Kiel, Germany, between 1954 and 1993 for ACC of the salivary
glands were analysed retrospectively. TNM-classification was
defined following the guidelines ofthe UICC (1987).
T andN classification was as follows: Tl: 8 (NO: 7, N1: 1); T2: 11
(NO: 10, NI: 1); T3: 15 (NO: 12, NI: 2, N2: 1); T4: 6 (NO: 4, N2:
2). Distant metastasis occured in 13 patients [26% (lung: 9, liver:
1, distant lymphatics: 1, skeleton: 2)]. Two of these patients
suffered from metastasis to multiple sites. Diagnosis of distant
metastasis was established between 0 and 172 months after
diagnosis of the primary tumor (average 63 ± 61 months).
Following diagnosis ofdistant metastasis the average survival was
21 (± 24) months and five patients survived 2 or more years and in
some cases significantly longer.
Even though the rate ofdistant metastasis in ACC ofthe salivary
glands is high patients often survive for many years due to a slow
tumorprogression at the site ofmetastasis.
17.20
Selective neck dissection versus observation in the case of Ti
and T2 oral carcinoma
R. Schimming, U. Eckelt, Dept. of Oral and Maxillofacial Surgery,
University ofDresden, Germany
The purpose ofthis investigation was to compare selective neck
dissection (SND) versus observation for the surgical treatment of
TI and T2 squamous cell carcinoma ofthe oral cavity (SCCOC)
with clinically negative (NO) neck.
162 patients (70-T1/92-T2), treated surgically for SCCOC, entered
this retrospective study between 1974 and 1994. 57 patients
(12/45) underwent SND simultaneously with their surgery for the
primary tumor. L05 patients (58/47) did not receive neck surgery.
The outcomes measured include local recurrence, regional
metastasis, distant metastasis, failure free survival (FFS) and
overall survival (OS).
SND did not reduce the local recurrence rate (chi-squared test, p =
1.0) but did significantly diminish the regional metastasis rate (chi-
squared test, p = 0.04). The regional metastasis related mortality
was significantly decreased (chi-squared test, p = 0.03) forpatients
treated with SND. No significant correlation was observed in the
case ofFFS (Log-rank test, p = 0.7) as well as OS (Log-rank test,
p =0.7).
This study establishes that SND has a greater benefit in the
treatment ofTI and T2 SCCOC with clinically negative (NO) neck
than observation.Tumormarkers, Virus, Neck dissection, Miscellaneous 55
17.21
Different incisions to approach neck dissections
M.C. Heissenber; 'S. Hoft, 'B,M. Lippert, 2G.M. Zotter, 'J.A. Wemer,
'Dept. of Otorhinolaryngology, Head and Neck Surgery, University of
Kiel; 2Berlin, Germany
The idiom neck dissection (ND) for surgical approach to cancer disease
in the head and neck was first used by G.W. Crile in 1906. Beside the
development and evolution of surgical techniques like i.e. modified,
radical, supraomohyoidal ND several kinds of incisions to different and,
inoncological respects, identical NDs are established anddiscussed.
In our department we use a small variety of incision techniques
depending on tumor location, preoperative TNM-status, preoperative
treatment like radiation, and possible reconstructive surgery.
In the majority of cases the "hockey-stick-incision" is used. It offers a
wide exposure of the neck giving safe access to the compartment i-VI,
the occipital skull base and even most parts of the posterior neck. In
cases requiring extended posterior ND, the incision can be extended into
a "book incision" as described by E.D. Diaz et al. giving ex,ellent access
to all areas ofrisk. Generally, compartment I is safely approachable by
consequent skin retraction. In rare, individual cases the head and neck
surgeon could still extend the access into a modified de-Quervain-
incision. There is no common risk like tip necrosis as for instance using
Y-incisions. U-incisions are best used in patients who will receive a total
or partial laryngectomy combined with ND. A MacFee-incision with its
broad skin flap probably offers the best skin healing and is discussed for
patients with peripheral vascular disease or after radiation therapy. We
prefer MacFee-incisions in patients who, after tumor removal, will need
reconstructive surgery like free myocutaneous flaps.
In conclusion we think that for most NDs the "hockey-stick-incision"
offers safe access to all areas of risk and gives opportunity to extend the
incision ifneeded.
17.23
Clinical experience with intratumoral injection of cisplatin/epinephrine gel in
patients with tumor recurrences or regional metastases in head and neck
cancer
C. Kulkens, S. Hoft, B.M. Lippert, J.A. Wemer, Dept. of ORL, University of Kiel,
Genmany
Background: A new approach to treat patients with lymph node metastases in
the neck due to recurrent squamous cell carcinoma of the head and neck
(SCCHN) is using cisplatin/epinephrine gel (MPI 5010) for intratumoral
injection.
Patients and Methods: Fifteen patients with recurrent SSCHN have been
included into a currently ongoing multicentre, randomised, double-blind and
placebo-controlled study at the Department of Otorhinolaryngology, Head and
Neck Surgery, University of Kiel since June 1996. Twelve patients were
treated for local recurrences, three patients had regional lymph node
metastases in the neck which were treated by intralesional injections using
cisplatin/epinephrine gel.
Results: These three patients did not receive 6 injections according to protocol
because of disease progression at the target tumor or systemic disease
progression (i. e. development of distant metastases). Two patients developed
lung metastases and were switched to systemic chemotherapy after the third
injection. As a result one patient had a complete remission. The third patient's
general state of health deteriorated rapidly due to tumor progression.
Therefore, treatment was abandoned after the first injection. In 3 of 15 patients
treated for local reurrences no tumor could macro-/microscopically be
detected.
Conclusion: Intralesional chemotherapy is a new well tolerated an4 feasible
palliative approach to treat selected patients with recurrent SSCHN.
Intratumoral administration of cisplatin/epinephrine gel in patients with large
metastases however may cause complications. Treatment responses which
were observed in local recurrences could not be observed in lymph node
metastases. Further clinical studies will demonstrate the importance of this
new therapeutic approach.
17.22
The preservation of the spinal accessory nerve in case of
cervical metastases
J. Mrowetz, I. Karapantzos, R. Kehl, G. Kolmel, Dept. of ORL,
Marienhospital Stuttgart, Germany
The only indication to sacrifice the spinal accessory nerve during
neck dissection, similary to the hypoglossal nerve, is the certain
infiltration by metastases. To ascertain whether there is infiltration
ofthe nerve, it must not be sacrified ,,on principle", but it must be
explorativly dissected - and only be resected in case of metastatic
infiltration - from the oncologically inconspicuous area to the
metastatic area. Most frequently the dissection is carried out in
caudocephalad direction, for most cervical metastases occur in the
upper third ofthe neck. The method of uncovering the accessory
nervein the supraclavicular area will be described by the authors.
Our observations for more than 10 years have not shown any
difference concerning the frequency ofmetastatic recurrence in the
area of the spinal accessory nerve between preserving and
sacrifycing the nerve.
A permanent failure is not to be expected when the nerve is
prepared carefully, as done in the surgery ofthe parotid gland.
17.24
Prognostic evaluation of squamous cell carcinoma of the oral
cavity
T. Bundgaard, Dept. of Otolaryngology, University of Aarhus, Denmark
Introduction: Prognostic indicators that could assist in a more precise
selection of patients with oral cancer for diffentiated therapy would be
clinically valuable.
Methods: A consecutive series of 161 cases of intraoral squamous cell
carcinoma (SCC) occurring during a 5-year period in a population of 1.4
million inhabitants, was evaluated by histopathologic, stereologic,
clinical, and epidemiologic parameters.
Results: Univariate analysis established a significant prognostic value in
terms ofcause-sp&-ific survival for T stage, maximum tumor diameter, N
stage (N+/NO), alcohol consumption, sterologic estimates of nuclear
volume, and the histomorphologic parameters mode of invasion, pattem,
vascularinvasion, depth, and mean histologic score. Tobacco
consumption was borderline significant. A multivariate analysis using the
Cox proportional hazard analysis showed that both clinical (stage,
P<0.0001; size, P=0.0027), epidemiologic (tobacco consumption,
P=0.0054), morphohistopathologic (mode of invasion P<0.0001), and
stereologic (nuclear volume, P=0.0010) parameters had an independent
significant effect on survival. Twelve patients (25%) with stage I disease
had unfavorablehistologic and stereologic parameters. The observed
survival for these patients was 33% ± 18%. The observed survival for
stage I patients with more favorable histologic characteristics (n=36) was
76% ± 8%.
Conclusion: The use of a combination of clinical, histological,
epidemiologic, and stereologic parameters will assist the design of
treatment strategies for intraoral SCC including treatment ofthe neck.56 Tumor markers, Virus, Neck dissection, Miscellaneous
17.25
Importance of the N-status for prognosis and treatment in glottic
cancer patients
J. Buntzel', M. Glatzel2, D. Frohlich2, K. Kuttner', 'Dept. of ORL,
Plastic Surgery, 2Dept. ofRadiotherapy, Clinic ofSuhl, Germany
Objective: Besides the well known influence of lymphatic
metastasis on the follow-up and the prognosis of glottic cancer,
there are different opinions about the importance of this fact on
treatment decisions.
Material and methods: We analyzed the data of 178 patients with
glottic cancer who were treated at our departments between 1990
and 1995.
Results: The incidence ofN-positive disease (clinical picture, MRI
or CT or sonography) was 20,7%. It was dependent from the size
ofprimary tumor: T2 - 11,8% N+disease, T3 - 37,0% N+disease,
T4 - 52,0% N+disease. The 5-years-survival-rates differed
significantly between NO- and N+disease: 86% versus '9%. In the
case of lymphatic metastasis of glottic cancer our standard
treatment (64,9%) was a neck dissection of the lymph-node
positive side, followed by an adjunctive radiotherapy (60 Gy total
dose, 2 Gy single dose, daily fraction). 13,5% ofall patients were
treated by primary radiochemotherapy (simultaneous in
combination with carboplatin). 21,5% ofN+patients wished to be
treated only by surgery. If the N+patients got the standard
treatment the 5-years-survival-rate was 62% compared to 45%
following surgical treatment alone.
Conclusion: The treatment of advanced glottic cancer with
lymphatic metastasis should include the microscopic resection of
the primary cancer, followed by the neck dissection and the
largefield radiation therapy ofthe cervical lymph nodes.
17.27
Verification of conformal head and neck irradiation techniques by
filmdosimetry
B. Schicker, U. Gotz, I.C. Kiricuta, Inst. of Radiation Oncology, St. Vincenz
Hospital, Limburg, Dept. ofBiomedical Technique, University ofGieBen, Germany
Purpose: In case ofhead and neck cancer we routinely apply conformal
3D - irradiation techniques. Due to the complex beam arrangement we
need a tool for quality assurance. In this study we show how calculated
dose distributions can be verified by the method of filmdosimetric
measurements.
Material and method: The measurements are carried out with a
humanoid phantom, which is divided up in several transversal slices
(Alderson - Phantom). A verification film (Kodak X Omat V) was placed
between two phantom slices. The transversal position of the film
corresponds tothe CT slice in which the dose distribution was calculated.
After irradiation the film was developed and scanned with a computer
controlled densitometer. The controlling software of the densitometer
allows a calibration ofthe optical densitiyin dose units [cGy].
The dose distribution on the film was compared with the calculated
distribution oftheplanningsystem.
Results: There is a good comprehension between the calculated and the
measured dose distributions within a few percent. The determination of
the absolute dose in the reference point depends on the exact knowledge
ofthe radiation response curve ofthe verification film.
Conclusion: The filmdosimetry is a simple and quick way to verify the
calculated dose distribution. The advantages ofthemethod are:
- Easyto handle
17.26
A clinico-pathological examination ofparastomal neoplasm etiology of
laryngeal carcinoma
F.U. Metternich, T. Brusis, Dept. of Otorhinolaryngology, Head and Neck
Surgery, Clinic Holweide, Cologne, Germany
Background/Patients: Parastomal neoplasm after total
Iaryngectomy for laryngeal carcinoma represents an extremely
serious complication. To clarify the controversial aspects of
parastomal neoplasm etiology, a systematic analysis wasperformed
using data from 2680 patients with total laryngectomy. Results:
Parastomal neoplasm occured in 6.4%. The tumour site of the
primary laryngeal carcinoma was found in 76.1% in the sublottic or
supraglottic area. If the laryngeal carcinoma was resected with
margins ofhealthy tissue, lymphatic metastasis to the pretracheal
and paratracheal cervical nodesisthe probable cause ofparastomal
neoplasm. The cervical metastasis formation cannot be detected
due to the limitations in the assessment of small lymph nodes in
radiologic imaging and due to the limitations in the removal of
lymph nodes in the pretracheal and paratracheal area by means ofa
functional or radical neck dissection. This could be the
consequence of the continuous lymphatic drainage between the
supraglottic and subglottic area -with a midline crossing and a
lymphatic outlet to the pretracheal and paratracheal cervical lymph
nodes. Conclusions: In cases of a patulous subglottic or
supraglottic laryngeal carcinoma the method of treatment should
be a laryagectomy and a bilateral neck dissection in combination
with an ipsilateral and contralateral pretracheal and paratracheal
lymph node removal.
17.28
Localization of primary tumor correlates significantly with the pattern of
initial metastasis in malignant melanoma
B. Schlagenhauff', M.M. Maassen2, C. Zimmermann', U. Ellwanger', W.
Stroebell, G. Rassner', C. Garbel, 'Dept. of Dermatology, 2Dept. of
Otolaryngology, University ofTubingen, Germany
At present, only limited information is available of factors
influencing the pattern of metastasis in malignant melanoma.
Therefore we conducted a study in order to investigate, if the
localization of the primary tumor of malignant melanoma had an
influence on itspattern ofinitial metastasis.
Data of 6705 patients with complete follow-up and primary
diagnosis from january 1976 until december 1995 were analyzed
using the chi-square-test and multiple logistic regression models.
Metastasis occured in 960 patients. Distribution oflocalization of
primary tumors (patients with metastases) were: head/neck: 944
(143), trunk: 2521 (400), upper extremity: 1098 (113), lower
extremity 2142 (304). Median controlperiod was 40 months.
Results indicated that the incidence of primary satellite/in-transit
metastasis was significantly higher in malignant melanoma found in
the head and neck region (33,6% of 143 patients) or in the lower
extremities (27,6% of 304 patients). Interestingly enough, in
malignant melanoma of the head and neck region, incidence of
satelfite/in-transit metastasis (33,6%), regional lymph node
metastasis (37,8%) or distant metastasis (28,7%) was similiar.
As a conclusion, in addition to tumor thickness, localization ofthe
primary tumor ofmalignant melanoma in the head and neckregion,
was a factor with impact on the initialpattern ofmetastasis.
- Quick check routine
- Needs fewtools (phantom, filmscanner)
- Usable for all treatmenttechniquesTumormarkers, Virus, Neck dissection, Miscellaneous 57
17.29
Metastasis of malignant melanoma from an unknown primary
site
V. Waldmann, A. Jackel, M. Bock, M. Deichmann, H. Naher, Dept. of
Dermatology, University ofHeidelberg, Germany
5-10% of patients with metastatic melanoma present with either
lymph node metastases or distant metastases, but no detectable
primary tumor can be found. It seems likely that, after exclusion of
an unusual site ofthe primary melanoma, as e.g. mucosa or uvea,
spontaneous regression of a primary melanoma has occured, with
persistence ofmetastases. In the present study, we present 7 cases
of metastasized melanoma with an unknown primary site first
diagnosed between 1992 and 1997 in the Department of
Dermatology of the University of Heidelberg. Of these, 4 males
(aged between 35 and 60 years at time of first diagnosis) and 3
females (49-71 years), 2 patients presented with skin metastases, 5
with lymhnode metastases. While both females with skin
metastases are free of additional metastases since 1 and 4 years,
the 5 patients with lymph node metastases had much shorter
survival time (> 5 months with no evidence ofdisease; 4 years until
death from liver and pleura metastases; 4, 6 and 6 months until
death from multiple visceral metastases). This prognosis seems
similar to patients whose primary melanomas had been excised and
argues against a relevant contribution of spontaneous regression
(through immunological mechanisms) to survival time.
17.31
Sinunasal melanoma: an analysis of30 cases
B.J. Folz', A.M. Niemann', B.M. Lippert', A. Hauschild2, J.A. Werner',
'Dept. of Otorhinolaryngology, Head and Neck Surgery, 2Dept. of
Dermatology, University ofKiel, Germany
Background: Mucosal melanoma of the sinonasal cavities is
fortunately a rare disease. The prognosis is expected to be
significantly worse than the prognosis ofcutaneous melanoma and
so far no uniformtherapeutic concept exists.
Patients: A group of thirty patients suffering from sinonasal
melanoma could be identified among the patients, who have sought
medical advice at the Dept. of ORL, Head and Neck Surgery of
the University of Kiel. Clinical data were obtained from the
patient's charts, the minimum follow-up was 24 months.
Results: Most common treatment was surgical resection, in some
cases combined with radiation therapy or chemotherapy.
Monotherapeutic treatment ofradiation or chemotherapy therapy
was rare. Patients who were treated by a combined approach had a
more favourable outcome than patients who were treated by a
monotherapy. A high number of recurrences could be observed,
which occured on an average of 16.6 months after the diagnosis of
the primary tumor. Regional or distant metastases were only
discovered in advanced cases. Overall survival was rather
disappointing.
Conclusions: An attempt to improve prognosis of sinonasal
melanoma might be the development of optimized combination
therapies. Intervals between follow-ups should be short to render
detection of recurrences at an early stage. Repeated therapy of
recurrent disease might lengthen survival.
17.30
Chemotherapy of metastatic malignant melanoma - outcome
ofdifferent treatment protocols
M. Bock, V. Waldmann, A. Jackel, M. Deichmann, H. Naher, Dept. of
Dermatology, University ofHeidelberg, Germany
Malignant melanoma shows a high resistance against
chemotherapy and there are only slight effects ofremission for the
medial survival time.
In a retrospective study the results of chemo- and
chemoimmunotherapy of 56 patients of the Department of
Dermatology between 1993 and 1997 with disseminated malignant
melanoma were compared. Thirteen patients were treated with
dacarbazine. For 5 ofthese 13 patients (38%) treatment resulted in
objective response or stable disease. The median time until
progression was 6.6 months. Twenty-nine patients received
dacarbazine and interferon alfa-2a [a-IFN] (6 additionally
interleukin-2 [LL-2]). Within this group 9 (31%) were treated with
success with a median time of 6.5 months. A combination of
dacarbazine, vindesine, and cisplatin [DVP] was administered to
32 patients with a response rate of 43.8% (14/32). The median
time to response was 5.3 months. Additionally groups were treated
with fotemustine (10 patients/ I remission), BCNU + dacarbazine
+ hydroxyurea (3/0), dacarbazine + tamoxifen (3/0) and vindesine
+ a-IFN (1/0).
The medial time ofsurvival forpatients with at least one successful
therapy was 13.6 months compared to 7 months for patients with
progressive disease.
In summary the highest response rates could be achieved with
DVP although DVP was used in most ofthe cases as second-line
therapy.
17.32
CD44 expression in primary sinonasal melanomas
S. Regauer, A. Beham, Dept. ofPathology, University ofGraz, Austria
Primary sinonasal melanomas (SM) are aggressive, predominantly
hematogenously metastasizing malignant neoplasms with short
survival. Aberrant expression ofthe adhesion molecule CD44, the
principle hyaluronate receptor, has been linked to poor survival in
human cancers. We therefore examined 14 SM (8M/6F, mean age
68 yrs, mean survival 18 months) for the expression of CD44 by
immunohistochemistry (formalin-fixed, paraffin-embedded
sections) with CD44 isoform-specific monoclonal antibodies to
CD44 standard (std) andvariant isoforms (v).
A strong membranous expression ofCD44std, v5 and v6 was seen
in superficially invasive and in-situ melanomas, as well as in non-
tumorous respiratory/squamous metaplastic epithelium. In widely
invasive SM, membranous CD44std was identified in a large
proportion of melanoma cells with decreased staining in deeply
invasive SM. CD44v5 and v6 demonstrated a focal, weak and
diffuse cytoplasmic staining with loss of membranous staining in
invasive SM, with the exception of3 cases. No staining differences
among the different histological subtypes (amelanotic small blue
cell, epithelioid, pleomorphic, spindle cell and myxoid) were
identified.
A proposed mechanism for the rapid hematogenous dissemination
ofSM is loss ofcellular adhesion ofSM cells secondary to loss of
membranous CD44 expression, therefore facialitating tissue
infiltration and dissemination ofmelanoma cells.